Cargando…
Key sunitinib‐related biomarkers for renal cell carcinoma
BACKGROUND: Renal cell carcinoma (RCC) contributed to 403,262 new cases worldwide in 2018, which constitutes 2.2% of global cancer, nevertheless, sunitinib, one of the major targeted therapeutic agent for RCC, often developed invalid due to resistance. Emerging evidences suggested sunitinib can impa...
Autores principales: | Peng, Yun, Dong, Shiqiang, Song, Yuxuan, Hou, Dingkun, Wang, Lili, Li, Bowen, Wang, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495283/ https://www.ncbi.nlm.nih.gov/pubmed/34402193 http://dx.doi.org/10.1002/cam4.4206 |
Ejemplares similares
-
Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma
por: Zhong, Tingting, et al.
Publicado: (2022) -
Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma
por: Zhang, Haiping, et al.
Publicado: (2019) -
AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019) -
LINC00958 and HOXC13-AS as key candidate biomarkers in head and neck squamous cell carcinoma by integrated bioinformatics analysis
por: Xiong, Dan, et al.
Publicado: (2020) -
Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma
por: Peng, Lu-Shan, et al.
Publicado: (2023)